UK Watchdog Looks To Revive £89M Drug Pricing Fine
By Shayna Posses ( June 28, 2018, 9:43 PM EDT) -- The U.K. competition authority said Thursday it has asked to appeal a tribunal's decision ordering it to take a second look at a case wherein the watchdog slapped Pfizer and Flynn Pharma with a £89.4 million ($116.9 million) fine after finding excessive and unfair pricing of an anti-epilepsy drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.